Document is current
Any future updates will be listed below
-
Authors
Tadros, Audree B.
Sevilimedu, Varadan
Plitas, George
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30CA008748)
- License Information
-
More Information
Article History
Received: 21 January 2021
Accepted: 22 January 2021
First Online: 10 February 2021
Disclosure
: George Plitas serves on the advisory boards of Merck and Tizona, has provided uncompensated services to Rubius Therapeutics and Takeda, and holds intellectual property rights in and has received research funding from Takeda. None of these relationships are related to the content of this study in any way. All other authors declare no financial or other interests.
